MASSDEVICE ON CALL — Medtronic (NYSE:MDT) is looking to significantly boost its reach in China, country with “the world’s biggest diabetes epidemic,” according to a local report.
Medtronic diabetes group president and executive vice president Hooman Hakami told ShanghaiDaily.com that he estimates China will one day account for 20% of the company’s global diabetes revenues, up from the 2.5% it represents today.
Help employers find you! Check out all the jobs and post your resume.
